A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Phase 1/2 Unknown
260 enrolled
Vaccination With Flt3L, Radiation, and Poly-ICLC
Phase 1/2 Unknown
56 enrolled
CINDERELLA
Phase 1/2 Unknown
44 enrolled
IMX-110 in Patients With Advanced Solid Tumors
Phase 1/2 Unknown
70 enrolled
A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.
Phase 1/2 Unknown
116 enrolled
Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer
Phase 1/2 Unknown
44 enrolled
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Phase 1/2 Unknown
314 enrolled
Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer
Phase 1/2 Unknown
40 enrolled
A Phase â… b/â…¡ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.
Phase 1/2 Unknown
300 enrolled
PLEASURABLE
Phase 1/2 Unknown
59 enrolled
Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer
Phase 1/2 Unknown
40 enrolled
G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
Phase 1/2 Unknown
102 enrolled
Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases
Phase 1/2 Unknown
39 enrolled
68Ga PET/CT Imaging in Breast Cancer Patients
Phase 1/2 Unknown
50 enrolled
A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors
Phase 1/2 Unknown
233 enrolled
Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients
Phase 1/2 Unknown
95 enrolled
ImmunoBreast - A Phase Ib Study
Phase 1/2 Unknown
20 enrolled
A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients
Phase 1/2 Unknown
170 enrolled
METROmaJX
Phase 1/2 Unknown
197 enrolled
KORNELIA
Phase 1/2 Unknown
90 enrolled
Multi-4SCAR-T Therapy Targeting Breast Cancer
Phase 1/2 Unknown
100 enrolled
4SCAR-CD44v6 T Cell Therapy Targeting Cancer
Phase 1/2 Unknown
100 enrolled
A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors
Phase 1/2 Unknown
60 enrolled
Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer
Phase 1/2 Unknown
40 enrolled
Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer
Phase 1/2 Unknown
20 enrolled
Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor
Phase 1/2 Unknown
40 enrolled
Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer(NK)Cells
Phase 1/2 Unknown
200 enrolled
Circadian Thermal Sensing to Detect Breast Disease
Phase 1/2 Unknown
173 enrolled
Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer
Phase 1/2 Unknown
30 enrolled
Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors
Phase 1/2 Unknown
100 enrolled
Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast Cancer
Phase 1/2 Unknown
55 enrolled
The Safety and Efficacy of Jobelyn in the Treatment of Breast Cancer Patients
Phase 1/2 Unknown
60 enrolled
A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors
Phase 1/2 Unknown
50 enrolled
NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer
Phase 1/2 Unknown
29 enrolled
Limiting Chemotherapy Side Effects by Using Moxa
Phase 1/2 Unknown
25 enrolled
MANTICORE
Phase 1/2 Unknown
99 enrolled
VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer
Phase 1/2 Unknown
147 enrolled
Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers
Phase 1/2 Unknown
60 enrolled
A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors
Phase 1/2 Unknown
60 enrolled
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Phase 1/2 Unknown
50 enrolled
Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
Phase 1/2 Unknown
30 enrolled
Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer
Phase 1/2 Unknown
50 enrolled
Biological Therapy in Treating Women With Metastatic Breast Cancer
Phase 1/2 Unknown
60 enrolled
Clinical Trial of SAHA in Patients With Breast Cancer
Phase 1/2 Unknown
49 enrolled
Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy
Phase 1/2 Unknown
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma
Phase 1/2 Unknown
Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer
Phase 1/2 Unknown
70 enrolled
Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Phase 1/2 Unknown
60 enrolled
Cellular Immunotherapy Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer
Phase 1/2 Unknown
24 enrolled
Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer
Phase 1/2 Unknown
54 enrolled